Introduction: Mixed adenoneuroendocrine carcinomas (MANEC) are rare tumors, commonly treated in analogy to adenocarcinomas (AC) or neuroendocrine carcinomas (NEC) without systematic data regarding the optimal treatment strategy.
Aim(s): To analyze the treatment outcomes of MANEC patients.
Materials and methods: Updated retrospective analysis of all patients with MANEC at our center between 10/2001 and 09/2016.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Dr. med. Leonidas Apostolidis
To read results and conclusion, please login ...
Further abstracts you may be interested in